Coeptis Therapeutics, Inc.COEPNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-65.04%
↓ 102% below average
Average (8y)
3517.81%
Historical baseline
Range
High:31825.33%
Low:-100.00%
Volatility
907.5%
High variability
| Period | Value |
|---|---|
| 2024 | -65.04% |
| 2023 | 31825.33% |
| 2022 | 0.00% |
| 2021 | -100.00% |
| 2020 | 0.00% |
| 2019 | 0.00% |
| 2018 | 0.00% |
| 2005 | 0.00% |
| 2004 | 0.00% |